Clinical outcomes of endoscopic and microsurgical treatments in patients with hypertensive basal ganglia hemorrhage

Objective To evaluate the clinical outcomes of endoscopic and microsurgical treatments in patients with hypertensive basal ganglia hemorrhage (HBGH). Methods A retrospective analysis of clinical features of 37 patients received microsurgical treatment via transsylvian-transinsular approach or 32 patients received endoscopic treatment for evacuation of HBGH in our hospital from January 2011 to January 2015 was performed. The operation time, hematoma clearance rate, re-bleeding rate and prognoses of the patients were investigated. Results As compared with patients accepted microsurgical treatment, patients accepted endoscopic treatment had significantly shorter operation time, smaller peroperative bleeding volume, and shorter hemostatic time (P 0.05); 24 h after operation, GCS scores in patients accepted endoscopic treatment increased to 12.79±1.20, which had significant difference as compared with those in patients accepted microsurgical treatment (11.23±1.29, P<0.05). The cerebral edema volume in patients accepted endoscopic treatment and microsurgical treatment was (11.83±4.08) mL and (18.76±7.92) mL, with significant difference (t=6.460, P=0.000). The hematoma clearance and prognosis in patients accepted endoscopic treatment were better than those in patients accepted microsurgical treatment. Conclusion Endoscopic evacuation of hematoma for HBGH is efficient and safe, enjoying better efficacy than microsurgery. Key words: Hypertensive cerebral hemorrhage; Neuroendoscopy; Microsurgery